ACTION OF SULPHONYLUREAS,ORAL ANTICOAGULANTS & CYCLOSPORIN POTENTIATED, HENCE DOSE SHOULD BE REDUCED. ORAL ANTIDIABETICS (SULPHONYLUREAS), PHENYTOIN & FRUSEMIDE IN PATIENTS WITH HYPOALBUMINEMIA MAY NEED DOSE ADJUSTMENTS. FIBRATES HAVE BEEN REPORTED TO DISPLACE WARFARIN AND OTHER DRUGS FROM THEIR PROTEIN BINDING SITES.